331 related articles for article (PubMed ID: 7914153)
1. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
[TBL] [Abstract][Full Text] [Related]
2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
3. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
Delemarre-Van de Waal HA
Clin Endocrinol (Oxf); 1993 May; 38(5):473-80. PubMed ID: 8330443
[TBL] [Abstract][Full Text] [Related]
4. [Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism].
Tachiki H; Kumamoto Y; Itoh N; Maruta H; Tsukamoto T
Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):605-22. PubMed ID: 7796925
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.
Schopohl J
Hum Reprod; 1993 Nov; 8 Suppl 2():175-9. PubMed ID: 8276954
[TBL] [Abstract][Full Text] [Related]
7. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism.
Jones TH; Darne JF
Clin Endocrinol (Oxf); 1993 Feb; 38(2):203-8. PubMed ID: 8435901
[TBL] [Abstract][Full Text] [Related]
8. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
9. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up.
Vicari E; Mongioì A; Calogero AE; Moncada ML; Sidoti G; Polosa P; D'Agata R
Int J Androl; 1992 Aug; 15(4):320-9. PubMed ID: 1516981
[TBL] [Abstract][Full Text] [Related]
10. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
[TBL] [Abstract][Full Text] [Related]
11. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism.
Kung AW; Zhong YY; Lam KS; Wang C
Int J Androl; 1994 Oct; 17(5):241-7. PubMed ID: 7698849
[TBL] [Abstract][Full Text] [Related]
12. [The application of gonadotropin in treatment of male central hypogonadism].
Di FS; Cui YG; Jia Y
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):836-9. PubMed ID: 16316564
[TBL] [Abstract][Full Text] [Related]
13. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
[TBL] [Abstract][Full Text] [Related]
14. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size.
Burris AS; Rodbard HW; Winters SJ; Sherins RJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1144-51. PubMed ID: 3372679
[TBL] [Abstract][Full Text] [Related]
17. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin treatment of hypogonadotropic hypogonadal adolescents.
Bouvattier C; Tauber M; Jouret B; Chaussain JL; Rochiccioli P
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():339-44. PubMed ID: 10698599
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
Liu L; Chaudhari N; Corle D; Sherins RJ
Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
